361-375 of 847
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiersA New Hope for Patients with MS – The First FDA-Approved Biosimilar
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiersDiagnosing Suspected MS: A Review of the Updated Guidelines
Andrew Wilner, MD, FACP, FAAN
Eoin Flanagan, MB, BCh
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiersThe Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action CenterLocked Up in My Own Mind: Challenges in the Criminal Justice System
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action CenterClarity for Schizophrenia: The Latest in Drug Treatment
Brian P. McDonough, MD, FAAFP
- advertisement
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiersNew Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiersStudying the Safety of Discontinuing DMTs in MS Older Adults
Andrew Wilner, MD, FACP, FAAN
John R. Corboy, MD
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiersUncovering Disease Progression in Multiple Sclerosis
Sergio Baranzini, PhD
Could Excessive Sleeping Indicate Cognitive Decline in Older Adults?
What Your Patients Are Talking AboutCould Excessive Sleeping Indicate Cognitive Decline in Older Adults?
Brian P. McDonough, MD, FAAFP
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiersExamining the Correlation Between HIV & Neurocognitive Disorders
Jerome Lisk, MD, MBA, M.S., FAAN
Santosh Kumar, PhD
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
NeuroFrontiersPrescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ashley Baker, MSN, PMHNP
- advertisement
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiersNIH Study Identifies Cause for Long COVID Neurological Symptoms
Charles Turck, PharmD, BCPS, BCCCP
Avindra Nath, MD
Investigating a Therapy for Brain Metastases: A Growing Problem
Project Oncology®Investigating a Therapy for Brain Metastases: A Growing Problem
Charles Turck, PharmD, BCPS, BCCCP
Priscilla Brastianos, MD
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiersDiagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
Charles Turck, PharmD, BCPS, BCCCP
Lokesh Shahani, MD, PhD, MPH, FACP, FASAM
